Cardiotoxicity of human recombinant interleukin-2 in rats. A morphological study

Circulation
J ZhangV J Ferrans

Abstract

One of the side effects of interleukin 2 (IL-2) cancer immunotherapy in humans is the vascular leak syndrome, which is frequently associated with depression of myocardial function, myocarditis, and myocardial necrosis. To investigate this cardiotoxicity, IL-2 (three doses of 5 x 10(5) Cetus units/day i.p.) was given to rats for 2, 3, or 5 days. Heart, lung, liver, spleen, and kidney tissues were studied by light and electron microscopy and with immunoperoxidase techniques. Cardiac changes consisted of focal lymphocytic and eosinophilic infiltration, myocyte vacuolization, myofibrillar loss, and necrosis. Ultrastructural alterations included swelling of endothelial cells, with dissociation of intercellular junctions, migration of lymphocytes into the interstitium, and interstitial hemorrhage and edema. Close contact between infiltrating lymphocytes, particularly large granular lymphocytes, and cardiac myocytes was often observed in areas of tissue damage. All lesions were more severe on day 5 than on days 2 and 3. Immunoperoxidase stains demonstrated asialo GM1 ganglioside antibody-positive, granular lymphocytes to be much more frequent in myocardium of IL-2-treated rats than in that of control rats. Although we cannot exclude t...Continue Reading

References

Jun 1, 1979·European Journal of Immunology·W R McMaster, A F Williams
May 1, 1990·The Japanese Journal of Surgery·T AkiyoshiH Matsuoka
Apr 1, 1990·The American Journal of Medicine·L M SchuchterD S Ettinger
Sep 1, 1990·The Journal of Clinical Investigation·P A SobotkaJ X Thomas
Jan 1, 1989·Japanese Circulation Journal·H DeguchiK Kawamura
Apr 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K A MargolinM Roper
Jan 4, 1989·Journal of the National Cancer Institute·R NoraH J Silverman
Jan 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R E LeeS A Rosenberg
Dec 1, 1988·The American Journal of the Medical Sciences·F L GlauserR P Fairman
Sep 1, 1987·European Journal of Immunology·A M MiltenburgL C Paul
Jan 1, 1986·Annual Review of Immunology·R B HerbermanJ R Ortaldo
Jan 1, 1985·Annual Review of Immunology·P A Henkart
Dec 1, 1968·Journal of Ultrastructure Research·J A Rhodin
Apr 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M HsuH Fanger
Mar 1, 1980·European Journal of Immunology·M KasaiT Tada
Aug 1, 1980·European Journal of Immunology·R J BrideauA F Williams

❮ Previous
Next ❯

Citations

Nov 1, 1993·Journal of the American College of Cardiology·A HerskowitzA A Ansari
May 3, 2005·Cytokine·M RitterM Maisch
Dec 13, 2000·Journal of Molecular and Cellular Cardiology·C KishimotoM Kitazawa
Apr 23, 2011·The British Journal of Radiology·P ThavendiranathanS V Raman
Oct 6, 2006·Expert Review of Anticancer Therapy·Robin L Jones, Michael S Ewer
Jul 1, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Lars Slørdal, Olav Spigset
Nov 1, 1995·Ultrastructural Pathology·J MilinD Zivkov-Saponja
Sep 27, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Cynthia RackleyAndrew L Gilman
Jun 10, 2000·Memórias do Instituto Oswaldo Cruz·Z A Andrade
Feb 22, 2017·Current Cardiology Reports·Daniel Y WangJavid J Moslehi
Jan 29, 2019·Frontiers in Cardiovascular Medicine·Icia Santos-ZasHafid Ait-Oufella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.